Said one of the protesters released after his arrest: “We wanted to have Rubio hear that people are still thinking about #PEPFAR—and that people overseas are dying” because of the Trump administration’s dismantling of U.S. global health programs.
https://t.co/T6cGKwwDJA
Advocates are concerned that even though HIV meds are not impacted, the cuts could undermine adherence for Missourians with HIV. And with the state legislature adjourned for the year, a legislative solution is unlikely for now.
https://t.co/w9t40Dr8X7
The new budget provides $75 million for ADAP, maintains income eligibility at 400% of FPL and restores Biktarvy. But no premium assistance & direct-dispense enrollment capped at 21,000. Florida governor Ron DeSantis is expected to sign the bill into law.
https://t.co/OnBrWapcv4
The FDA has approved Idvynso, which combines 2 drugs made by Merck—doravirine (which has been available for several years under the brand name Pifeltro) + islatravir, the first of a new drug class, nucleoside reverse transcriptase translocation inhibitors. https://t.co/kOB542pV7X
Immigration raids, funding cuts and fear are disrupting HIV care for Latina/o communities. In a commentary for PA, Carlos Saldana Ochoa, MD, describes how missed appointments, detention and research instability threaten decades of HIV progress.
https://t.co/W8cMCffiYn
A pediatric formulation of ViiV’s HIV medication Dovato has been submitted to the FDA and European regulators for review. If approved, this version of the two-drug once-daily regimen could be used as treatment for children as young as 3 months old.
https://t.co/lPcayyBqot
“The silence still happens. But I no longer see it as something to push through or fill.”
Advocate Von Biggs writes about #HIV disclosure, stigma, advocacy and the moments when silence becomes possibility in a new First Person commentary for the magazine.
https://t.co/TXudiBuPpz
In a First Person commentary for PA, Michelle Anderson examines the gap between U=U science and the lived reality for Black people living with #HIV—where stigma, criminalization and systemic racism still shape healthcare, disclosure and safety.
https://t.co/8XxlnhsdpH
When we dismiss tools like PrEP or DoxyPEP because they don’t align with our beliefs, we’re not protecting anyone, writes public health advocate Jason Watler. Too often people disguise their antagonism to some sexual health interventions as morality.
https://t.co/yKfhM5kygc
An op-ed by @PrEP4AllNow’s @ActivistJohnson as California’s state supreme court hears oral arguments in a lawsuit by 24,000 people living HIV, charging that Gilead Sciences delayed development of a safer version of tenofovir in order to protect profits.
https://t.co/jxATmbcmKb
Single-tablet regimens simplify HIV treatment, improve adherence and help prevent resistance and transmission. In a First Person commentary, policy advocate Scott Bertani notes that some cost-cutting efforts fail to take into accounts these benefits.
https://t.co/6zYcQo0Cjb
To see someone as the person they are is the beginning of respect.
To see someone as the person they are is the beginning of compassion.
To see someone as the person they are is the beginning.
International Transgender Day of Visibility
“I knew how I wanted my hair, nails, outfit, coffin & what funeral home I wanted it to be at,” writes Kim Canady for @posaware. “I have to remember that I’m here for a reason. I’m in a constant fight with myself to not just be alive but to actually live!” https://t.co/rYg1L5GdAS
After April 1, the U.S. post office will no longer ship bulk copies of magazines in bundles, so PA is switching to UPS. Now’s the time to update your shipping info—address, quantities and contact info. Or place your new order! Contact us: [email protected].
The federal government no longer recognizes National HIV/AIDS Awareness Days. That’s why we the people need to stand up and call out how HIV impacts our communities.
#NHAAD
The funding bill was presented to Gov. DeSantis on March 18; lawmakers expect it to be signed possibly within days, though no timeline has been confirmed. Gaps remind. Biktarvy is still off the #ADAP formulary; Descovy is subject to restricted use.
https://t.co/dsXffIEkPr
Watch actor-performer Keiynan Lonsdale talk with Positively Aware special correspondent Tony Morrison about exploring his sexuality and identity through creativity—and about being on PrEP.
https://t.co/A4gWCFI1cn